Found: 76
Select item for more details and to access through your institution.
Patient voice on management of facial dermatological adverse events with targeted therapies: a qualitative study.
- Published in:
- Journal of Patient-Reported Outcomes, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41687-019-0116-3
- By:
- Publication type:
- Article
Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99364-z
- By:
- Publication type:
- Article
Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti- Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype
- Published in:
- Journal of Gastroenterology, 2012, v. 47, n. 9, p. 969, doi. 10.1007/s00535-012-0566-3
- By:
- Publication type:
- Article
Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett’s esophagus.
- Published in:
- Journal of Gastroenterology, 2004, v. 39, n. 1, p. 14, doi. 10.1007/s00535-003-1239-z
- By:
- Publication type:
- Article
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 199, doi. 10.1093/jjco/hyaa190
- By:
- Publication type:
- Article
Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 4, p. 389, doi. 10.1093/jjco/hyv211
- By:
- Publication type:
- Article
Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 2, p. 111, doi. 10.1093/jjco/hyv183
- By:
- Publication type:
- Article
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 2, p. 460, doi. 10.1245/s10434-019-07654-8
- By:
- Publication type:
- Article
Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 939, doi. 10.1007/s10637-018-0589-6
- By:
- Publication type:
- Article
Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 1, p. 60, doi. 10.1007/s10147-018-1336-x
- By:
- Publication type:
- Article
Concordance of clinical diagnosis of T classification among physicians for locally advanced unresectable thoracic esophageal cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 73, doi. 10.1007/s10147-017-1168-0
- By:
- Publication type:
- Article
Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 1, p. 105, doi. 10.1007/s10147-014-0691-5
- By:
- Publication type:
- Article
Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 5, p. 488, doi. 10.1007/s10147-011-0213-7
- By:
- Publication type:
- Article
Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 144, doi. 10.1007/s10147-007-0737-z
- By:
- Publication type:
- Article
A case of multiple protruding and flat colorectal tumors analyzed by a cDNA array.
- Published in:
- 2007
- By:
- Publication type:
- Letter
A case of pneumatosis cystoides intestinalis with dermatomyositis in which EUS was useful for the diagnosis.
- Published in:
- 2005
- By:
- Publication type:
- Letter
A case of colorectal carcinoma in adenoma analyzed by a cDNA array.
- Published in:
- International Journal of Colorectal Disease, 2005, v. 20, n. 3, p. 287, doi. 10.1007/s00384-004-0656-7
- By:
- Publication type:
- Article
The Relationship between Frailty and Quality of Life in Older Digestive Cancer Patients when Choosing an Anticancer Drug Regimen.
- Published in:
- Journal of Japan Academy of Nursing Science, 2022, v. 42, p. 254, doi. 10.5630/jans.42.254
- By:
- Publication type:
- Article
Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12653-4
- By:
- Publication type:
- Article
Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1046, doi. 10.1007/s10637-010-9630-0
- By:
- Publication type:
- Article
Erratum to: Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 8, p. e198243, doi. 10.1001/jamanetworkopen.2019.8243
- By:
- Publication type:
- Article
Complications in advanced or recurrent gastric cancer patients with peritoneal metastasis during and after palliative systemic chemotherapy.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 3, p. 539, doi. 10.3892/mco.2015.510
- By:
- Publication type:
- Article
Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106).
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 10, p. 972
- By:
- Publication type:
- Article
Phase III Trial of Everolimus in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from RECORD-1.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 17, doi. 10.1093/jjco/hyq166
- By:
- Publication type:
- Article
Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 10, p. 913, doi. 10.1093/jjco/hyq069
- By:
- Publication type:
- Article
Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 6, p. 573
- By:
- Publication type:
- Article
A Phase 2 Clinical Trial of Panitumumab Monotherapy in Japanese Patients with Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 5, p. 321, doi. 10.1093/jjco/hyp016
- By:
- Publication type:
- Article
Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF<sup>V600E</sup> Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study).
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 4, p. 949, doi. 10.1007/s00280-011-1783-9
- By:
- Publication type:
- Article
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1265, doi. 10.1007/s00280-010-1422-x
- By:
- Publication type:
- Article
PS02.162: THREE-YEAR OVERALL SURVIVAL UPDATE FROM PHASE II STUDY OF CHEMOSELECTION WITH DCF AND SUBSEQUENT CONVERSION SURGERY FOR LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL CANCER.
- Published in:
- Diseases of the Esophagus, 2018, v. 31, n. 13, p. 167, doi. 10.1093/dote/doy089.PS02.162
- By:
- Publication type:
- Article
Interaction between Medical Treatment and Minimally Invasive Surgical Treatment for the Malignancies of the Digestive Tract.
- Published in:
- Digestion, 2018, v. 97, n. 1, p. 13, doi. 10.1159/000484033
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and efficacy of FOLFIRI plus bevacizumab in Japanese colorectal cancer patients with UGT1A1 gene polymorphisms.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 5, p. 495, doi. 10.1002/jcph.246
- By:
- Publication type:
- Article
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 1032, doi. 10.1038/s41416-023-02378-9
- By:
- Publication type:
- Article
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 207, doi. 10.1007/s10120-021-01230-4
- By:
- Publication type:
- Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 946, doi. 10.1007/s10120-021-01173-w
- By:
- Publication type:
- Article
Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascites.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 3, p. 363, doi. 10.1007/s10120-020-01067-3
- By:
- Publication type:
- Article
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 3, p. 510, doi. 10.1007/s10120-019-01034-7
- By:
- Publication type:
- Article
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 143, doi. 10.1007/s10120-019-00970-8
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 429, doi. 10.1007/s10120-017-0773-y
- By:
- Publication type:
- Article
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 876, doi. 10.1007/s10120-015-0536-6
- By:
- Publication type:
- Article